版本:
中国

BRIEF-Valeritas' V-Go wearable insulin delivery device results in significant reductions in A1C

May 22 Valeritas Holdings Inc:

* Valeritas' V-Go wearable insulin delivery device results in significant reductions in A1C, insulin requirements and cost reductions in patients with diabetes Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐